KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, intestinal disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, rectal disorder	Recruiting	Phase 1	2026-07-31		NCT06411691

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Agenus Inc.	23
National Cancer Institute (NCI)	3015
Private Philanthropic Funds	4
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	117
United States Department of Defense	319

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Sidney Kimmel Comprehensive Cancer Center	Baltimore	United States	9